asn.dev

Autonomous system

AS824 GLAXOSMITHKLINE

Unclassified ARIN

IPv4 addresses 512 1 prefixes
IPv6 prefixes 0 counted as prefixes, not addresses
Countries 1 mostly US
Flagged prefixes 0 none

Summary

GlaxoSmithKline (GSK)

United States · AI-generated

enterprise legacy

A corporate network of GlaxoSmithKline (GLAXOSMITHKLINE), the global pharmaceutical and consumer-health company, covering its US operations (registered in Pennsylvania).

What it's used for

  • Enterprise networking for a large pharmaceutical company: corporate, research, and site connectivity.

Notable

  • A private corporate network, not a commercial ISP or host. The low AS number reflects an early ARIN allocation from the mid-1990s.

This description is AI-generated, best-effort context — not authoritative, and provided without any guarantee of accuracy. Source, and how to suggest an edit.

Address space

Summary

Full explorer
CountryNamePrefixes
USUnited States of America1

Registry

Allocation record

via ARIN RDAP
Registry
ARIN
Handle
AS824
Registry name
GLAXOSMITHKLINE
Registrant
GlaxoSmithKline
Abuse contact
csir@gsk.com
Registered
1994-03-29
Last changed
2007-06-08
Status
active

Reputation

Classification and threat

Unclassified Not in the curated lists. Most of the ~80,000 allocated ASNs are not.

No IC3 indicators Nothing from the FBI IC3 feed.

Threat data is alpha. Absence of an indicator is not evidence of good behaviour, only of absence from this one feed.

Elsewhere

Cross-check